Exane Derivatives’s Texas Capital Bancshares TCBI Stock Holding History

Exane Derivatives’s Portfolio TCBI Stock Details TCBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,883	Closed	-$108K	–	915
2022 Q1	$108K	Buy	+1,883	New	+$120K	0.03%	463
2019 Q2	–	Sell	-1,857	Closed	-$101K	–	714
2019 Q1	$101K	Sell	1,857 -413	-18%	-$23.9K	0.02%	293
2018 Q4	$116K	Hold	2,270	–	–	0.02%	306
2018 Q3	$188K	Sell	2,270 -60	-3%	-$5.44K	0.04%	255
2018 Q2	$217K	Sell	2,330 -582	-20%	-$56.4K	0.04%	256
2018 Q1	$256K	Buy	2,912 +62	+2%	+$5.81K	0.05%	225
2017 Q4	$253K	Buy	2,850 +1,254	+79%	+$109K	0.04%	222
2017 Q3	$137K	Sell	1,596 -17	-1%	-$1.32K	0.03%	224
2017 Q2	$125K	Buy	+1,613	New	+$124K	0.03%	250

Other funds holding TCBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's TCBI Position: Q2 2022 in Review

Exane Derivatives sold out of Texas Capital Bancshares (TCBI) in Q2 2022, closing a stake of 1,883 shares — an estimated $108K sold.

Exane Derivatives first reported a position in TCBI in Q2 2017 and held it in 9 quarters. The position peaked at $256K in Q1 2018. 227 funds tracked by Wall St. Rank hold TCBI as of Q2 2022.

Exane Derivatives reported no remaining Texas Capital Bancshares position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 1,883 Texas Capital Bancshares shares in Q2 2022, an estimated $108K.
Exane Derivatives first reported a position in Texas Capital Bancshares in Q2 2017 and held it in 9 quarters.
Exane Derivatives's Texas Capital Bancshares position peaked at $256K in Q1 2018.
227 funds tracked by Wall St. Rank held Texas Capital Bancshares as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.